RxDoctor Payments Data

Sanjay Mohindra, MD

Vascular & Interventional Radiology · Lafayette, INNPI 1881649176

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,514 of the $8,477 with a category attached, or 76.8%. 18 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 35.7% of the total. Reporting peaked in 2024 at $3,106 and has fallen 80.3% since, to $611 in 2025.

$8,477in general payments, 2019–2025

Across 124 payments — averaging $68.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$3K
  • Mozarc Medical US LLC$1K
  • Boston Scientific$927
  • Philips North America LLC$466
  • Terumo Medical Corporation$441
  • Medtronic$414
  • plus $2K from 12 others

What the payments were for

  • Travel & lodging$1,96323%
  • Food & beverage$6,51477%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,477 in reported general payments places this provider in the 55th percentile of 74 vascular & interventional radiology providers in Indiana.

See all vascular & interventional radiology providers in Indiana

Medicare billing

Part B allowed, 2024
$98,541
Medicare patients
181
Services billed
839

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban36$21,033
Prednisone84$74
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$22

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Lafayette

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →